BiotechTube

Descovy

ApprovedCompleted
0 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

HIV Prevention

Conditions

HIV Prevention

Trial Timeline

Jul 19, 2022 → Mar 21, 2025

NCT ID
NCT05528653

About Descovy

Descovy is a approved stage product being developed by Gilead Sciences for HIV Prevention. The current trial status is completed. This product is registered under clinical trial identifier NCT05528653. Target conditions include HIV Prevention.

What happened to similar drugs?

5 of 20 similar drugs in HIV Prevention were approved

Approved (5) Terminated (0) Active (15)
🔄edoxaban + enoxaparin sodiumDaiichi SankyoPhase 3
🔄DAPA/MET XR + DAPA + MET XRAstraZenecaPhase 3
🔄Esomeprazole + PlaceboAstraZenecaPhase 3
✅RaltegravirMerckApproved
🔄RotaTeq (V260) + IPVMerckPhase 3
🔄V501MerckPhase 3
🔄ZostavaxMerckPhase 3

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT05690815Pre-clinicalActive
NCT05528653ApprovedCompleted

Competing Products

20 competing products in HIV Prevention

See all competitors
ProductCompanyStageHype Score
mRNA-1944ModernaPhase 1
0
Gam-COVID-VacDr. Reddy's LaboratoriesPhase 2/3
31
edoxaban + enoxaparin sodiumDaiichi SankyoPhase 3
40
MifepristoneEli LillyPhase 2
35
EXANTAAstraZenecaPhase 2
27
Risk of low dose aspirin discontinuationAstraZenecaPre-clinical
26
DAPA/MET XR + DAPA + MET XRAstraZenecaPhase 3
40
Esomeprazole + PlaceboAstraZenecaPhase 3
40
PCV15MerckPre-clinical
18
RaltegravirMerckApproved
43
RotaTeq (V260) + IPVMerckPhase 3
40
V501MerckPhase 3
40
ZostavaxMerckPhase 3
40
V920 Consistency Lot A + V920 Consistency Lot B + V920 Consistency Lot C + V920 High-dose Lot + Placebo to V920MerckPhase 3
40
Letermovir + PlaceboMerckPhase 3
40
Meningococcal C conjugate vaccineNovartisApproved
43
Enteric-coated mycophenolate sodiumNovartisPhase 3
40
Meningococcal C conjugate vaccineNovartisApproved
43
rMenB+OMV NZNovartisPhase 3
40
Enteric-Coated Mycophenolate SodiumNovartisPhase 3
40